APA (7th ed.) Citation

Venketasubramanian, N., Silva, D. A. D., Chen, C. P. L. H., Escabillas, C. G., Hiyadan, J. H., Lokin, J. K., . . . Tham, C. H. Phase II randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of MLC1501 in patients with stroke: The MLC1501 study Assessing Efficacy in post-STrOke Subjects with mOtor deficits (MAESTOSO) study protocol. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Venketasubramanian, Narayanaswamy, et al. Phase II Randomised, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of MLC1501 in Patients with Stroke: The MLC1501 Study Assessing Efficacy in Post-STrOke Subjects with MOtor Deficits (MAESTOSO) Study Protocol. BMJ Publishing Group.

MLA (9th ed.) Citation

Venketasubramanian, Narayanaswamy, et al. Phase II Randomised, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of MLC1501 in Patients with Stroke: The MLC1501 Study Assessing Efficacy in Post-STrOke Subjects with MOtor Deficits (MAESTOSO) Study Protocol. BMJ Publishing Group.